359 related articles for article (PubMed ID: 9750003)
1. Riluzole, a glutamate release inhibitor, and motor behavior.
Kretschmer BD; Kratzer U; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):181-90. PubMed ID: 9750003
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptors.
Kretschmer BD
J Neurochem; 1999 Aug; 73(2):839-48. PubMed ID: 10428083
[TBL] [Abstract][Full Text] [Related]
3. Dopamine-glutamate interplay in the ventral striatum modulates spatial learning in a receptor subtype-dependent manner.
Coccurello R; Oliverio A; Mele A
Neuropsychopharmacology; 2012 Apr; 37(5):1122-33. PubMed ID: 22218092
[TBL] [Abstract][Full Text] [Related]
4. Motor stimulation following bilateral injection of the group-I metabotropic glutamate receptor agonist into the dorsal striatum of rats: evidence against dependence on ionotropic glutamate receptors.
Mao L; Wang JQ
Psychopharmacology (Berl); 2000 Mar; 148(4):367-73. PubMed ID: 10928309
[TBL] [Abstract][Full Text] [Related]
5. Some central effects of GYKI 52466, a non-competitive AMPA receptor antagonist.
Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
Pol J Pharmacol; 1995; 47(6):501-7. PubMed ID: 8868372
[TBL] [Abstract][Full Text] [Related]
6. Regulation of NMDA-stimulated [14C]GABA and [3H]acetylcholine release by striatal glutamate and dopamine receptors.
Hanania T; Johnson KM
Brain Res; 1999 Oct; 844(1-2):106-17. PubMed ID: 10536266
[TBL] [Abstract][Full Text] [Related]
7. Effects of decahydroisoquinoline-3-carboxylic acid monohydrate, a novel AMPA receptor antagonist, on glutamate-induced CA2+ responses and neurotoxicity in rat cortical and cerebellar granule neurons.
Liljequist S; Cebers G; Kalda A
Biochem Pharmacol; 1995 Nov; 50(11):1761-74. PubMed ID: 8615854
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-independent locomotion following blockade of N-methyl-D-aspartate receptors in the ventral tegmental area.
Cornish JL; Nakamura M; Kalivas PW
J Pharmacol Exp Ther; 2001 Jul; 298(1):226-33. PubMed ID: 11408546
[TBL] [Abstract][Full Text] [Related]
9. Effects of AMPA receptor antagonists on dopamine-mediated behaviors in mice.
Vanover KE
Psychopharmacology (Berl); 1998 Mar; 136(2):123-31. PubMed ID: 9551768
[TBL] [Abstract][Full Text] [Related]
10. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.
Hauber W; Andersen R
Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):486-90. PubMed ID: 8114947
[TBL] [Abstract][Full Text] [Related]
11. Riluzole attenuates the effects of chemoconvulsants acting on glutamatergic and GABAergic neurotransmission in the planarian Dugesia tigrina.
Ramakrishnan L; Dalhoff Z; Fettig SL; Eggerichs MR; Nelson BE; Shrestha B; Elshikh AH; Karki P
Eur J Pharmacol; 2013 Oct; 718(1-3):493-501. PubMed ID: 23872399
[TBL] [Abstract][Full Text] [Related]
12. Lowered brain stimulation reward thresholds in rats treated with a combination of caffeine and N-methyl-D-aspartate but not alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate or metabotropic glutamate receptor-5 receptor antagonists.
Bespalov A; Dravolina O; Belozertseva I; Adamcio B; Zvartau E
Behav Pharmacol; 2006 Jun; 17(4):295-302. PubMed ID: 16914947
[TBL] [Abstract][Full Text] [Related]
13. Excitatory amino acids and synaptic transmission in embryonic rat brainstem motoneurons in organotypic culture.
Launey T; Ivanov A; Kapus G; Ferrand N; Tarnawa I; Gueritaud JP
Eur J Neurosci; 1999 Apr; 11(4):1324-34. PubMed ID: 10103128
[TBL] [Abstract][Full Text] [Related]
14. Non-NMDA receptor-mediated mechanisms are involved in levodopa-induced motor response alterations in Parkinsonian rats.
Marin C; Jimenez A; Bonastre M; Chase TN; Tolosa E
Synapse; 2000 Jun; 36(4):267-74. PubMed ID: 10819904
[TBL] [Abstract][Full Text] [Related]
15. Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD.
Bibbiani F; Oh JD; Kielaite A; Collins MA; Smith C; Chase TN
Exp Neurol; 2005 Dec; 196(2):422-9. PubMed ID: 16203001
[TBL] [Abstract][Full Text] [Related]
16. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
Melo LL; Santos P; Medeiros P; Mello RO; Ferrari EA; Brandão ML; Maisonnette SS; Francisco A; Coimbra NC
Brain Res; 2010 Aug; 1349():41-7. PubMed ID: 20558148
[TBL] [Abstract][Full Text] [Related]
17. Activation of striatal group II metabotropic glutamate receptors has a differential effect on dopamine-D1 and -D2 receptor antagonist-induced hypokinesia in the rat.
Kronthaler UO; Schmidt WJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):289-97. PubMed ID: 10731042
[TBL] [Abstract][Full Text] [Related]
18. Impairments of movement initiation and execution induced by a blockade of dopamine D1 or D2 receptors are reversed by a blockade of N-methyl-D-aspartate receptors.
Hauber W
Neuroscience; 1996 Jul; 73(1):121-30. PubMed ID: 8783236
[TBL] [Abstract][Full Text] [Related]
19. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
Tzschentke TM; Schmidt WJ
Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
[TBL] [Abstract][Full Text] [Related]
20. Effect of intracerebral administration of NMDA and AMPA on dopamine and glutamate release in the ventral pallidum and on motor behavior.
Kretschmer BD; Goiny M; Herrera-Marschitz M
J Neurochem; 2000 May; 74(5):2049-57. PubMed ID: 10800948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
